Stockpolly
Search
Delisting risk
ADGM · NASDAQ · Medical - Devices

Adagio Medical (ADGM)

Catheter-based ablation systems for ventricular tachycardia built on ultra-low-temperature technology.

$0.5250
Pre-market−0.01 (−1.74%)
At close$0.5343(+4.27%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue001112000000
Gross profit00−100−1000000
9586107746455
Research & development423323423232
435384323222
Selling & marketing000002000000
General & administrative000002000002
Operating income−9−5−9−7−11−9−7−5−6−4−5−5
−2−4116−4901−41−2−2
Interest income000001000000
Interest expense011110111111
Other non-operating income13−2−2−700−14−111
Income before tax−11−9−8−6−5−57−8−4−10−3−7−7
Net income from continuing operations−11−9−8−6−5−57−8−4−10−3−7−7
Net income−11−9−8−6−5−57−8−4−10−3−7−7
EPS, basic−$0.80−$0.28−$0.03−$0.43−$0.32−$3.55−$0.50−$0.26−$0.66−$0.16−$0.31−$0.30
EPS, diluted−$0.80−$0.28−$0.03−$0.43−$0.32−$3.55−$0.50−$0.35−$0.66−$0.16−$0.31−$0.30
Weighted average shares, basic1388131515151515202222
Weighted average shares, diluted1388131515151515202222
EBITDA−10−8−7−5−4−8−7−3−9−2−6−6
Depreciation & amortization000000000000
EBIT−10−9−7−5−4−9−7−3−9−3−6−6